New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2012
12:15 EDTERIC, AMLN, RDEA, FB, XRX, PFE, STM, CEDC, AOL, CHKP, EAT, WMMVY, ACHN, AZN, MSFT, HAS, NSRGY, WMTOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday, as European political uncertainty and a bribery investigation at Wal-Mart (WMT) kicked the week off on a sour note. Fresh concerns over the European debt crisis have caused a sell off in Europe and here in the U.S. The culprits this time were the failure by the Dutch government to agree on austerity measures and the first round of the French elections going to the Socialist party's candidate. There has been nothing on the U.S. economic calendar to turn investor's attention away from Europe, lending to broad based weakness in equities... ECONOMIC EVENTS: Domestically, little of note was on the economic calendar. In Europe, Markit's composite purchase managers' index fell to 47.4 points in April and political developments added to fears that the region's debt crisis could worsen, as the Netherlands' Prime Minister and his cabinet resigned after budget talks broke down and France's incumbent Nicolas Sarkozy lost in the first round of the nation's presidential elections. In China, a flash PMI reading rose to 49.1 in April, but that improved figure still signals contraction in the manufacturing industry... COMPANY NEWS: Shares of Wal-Mart dragged on the Dow, declining 4.6% after The New York Times said the company focused on damage control instead of fixing problems after finding "evidence of widespread" bribery at Wal-Mart de Mexico (WMMVY). Another Dow component, Pfizer (PFE), also slid following major news, falling almost 1% after agreeing to sell its Nutrition business to Nestle (NSRGY) for $11.85B... Among companies reporting earnings, advancers included Brinker (EAT) and Xerox (XRX); decliners included Hasbro (HAS) and Check Point (CHKP)... Facebook (FB) announced plans to buy a part of the patent portfolio Microsoft (MSFT) recently agreed to acquire from AOL (AOL)... MAJOR MOVERS: Among the notable gainers were Ardea Biosciences (RDEA), up 52%, on news it will be acquired by AstraZeneca (AZN) for $32 per share, and Central European Distribution (CEDC), up 14%, after Russian Standard agreed to invest $100M in the company as part of a strategic alliance. Also higher were shares of Amylin (AMLN), up 10%, after Reuters said over the weekend that the company has hired banks to explore a potential sale. Noteworthy losers included Achillion (ACHN), down over 18%, following a downgrade at JMP Securities after the release of interim ACH-1625 data at a conference over the weekend, and STMicroelectronics (STM), down 11%, after ST-Ericsson, its 50/50 joint venture with Ericsson (ERIC), said it will cut 1,700 jobs amid plans to pursue a new strategic direction... INDICES: Near noon, the Dow was down 135.02, or 1.04%, to 12,894.24; the Nasdaq was down 37.42, or 1.25%, to 2,963.03; and the S&P 500 was down 13.96, or 1.01%, to 1,364.57.
News For WMT;WMMVY;PFE;NSRGY;EAT;XRX;HAS;CHKP;FB;MSFT;AOL;RDEA;AZN;CEDC;AMLN;ACHN;STM;ERIC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 >>
January 29, 2016
07:28 EDTXRXXerox to hold a conference call
Management discusses the company separating into two independent publicly-traded companies on a conference call to be held on January 29 at 10 am. Webcast Link
07:16 EDTXRXXerox CEO says would field any offers if bidders expressed interest
Subscribe for More Information
07:13 EDTXRXBurns says 'big shift' in healthcare markets played role in break-up decision
Subscribe for More Information
07:11 EDTAZNAllergan enters into global agreement with AstraZeneca for ATM-AVI
Allergan announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam. Together, the two companies will evaluate the combination to treat serious infections caused by metallo betalactamase MBL-producing Gram-negative pathogens, a difficult-to-treat sub-type of carbapenem-resistant Enterobacteriaceae, or CRE, for which there are currently very limited treatments, thus presenting a new treatment option for patients with MBL-producing pathogens. Under the terms of the agreement, Allergan will maintain commercialization rights in the U.S. and Canada and AstraZeneca will maintain commercialization rights in all other countries.
07:05 EDTXRXXerox CEO: Icahn had 'nothing to do' with initiating review that led to split
Xerox Chairman and CEO Ursula Burns is speaking on CNBC.
06:51 EDTWMTJury says Wal-Mart must by pharmacist $31.22M in gender bias case, Reuters says
Subscribe for More Information
06:49 EDTXRXXerox board increases quarterly dividend 11% to 7.75c per share
Subscribe for More Information
06:49 EDTXRXXerox sees Q1 adjusted EPS 21c-24c, consensus 21c
Subscribe for More Information
06:49 EDTXRXXerox and Carl Icahan enter agreement related to governance of BPO
Xerox and Carl C. Icahn announced that they have entered into an agreement related to the governance of the Business Process Outsourcing company that will be created as a result of the planned separation of Xerox into two independent, publicly-traded companies, which was announced earlier today. Under the agreement, when the separation is complete, the BPO company will have certain best-in-class corporate governance provisions and a Board of Directors composed of nine members: six directors selected by Xerox and three directors selected by Icahn. In addition, in connection with the planned separation, Xerox agreed that a committee of its Board of Directors will begin searching for an external candidate to be Chief Executive Officer of the BPO company and to allow a person selected by Icahn to observe and advise the committee in that search process.
06:49 EDTXRXXerox sees FY16 adjusted EPS $1.10-$1.20, consensus 99c
Subscribe for More Information
06:48 EDTXRXXerox reports Q4 adjusted EPS 32c, consensus 28c
Subscribe for More Information
06:48 EDTXRXXerox to begin separation process when it finalizes transaction structure
Subscribe for More Information
06:47 EDTXRXXerox announces three year strategic transformation program
Subscribe for More Information
06:47 EDTXRXXerox to separate into two public companies
Xerox announced today the results of its review of the company's portfolio and capital allocation options announced in October 2015. The board of the company has unanimously approved management's plan to separate Xerox into two independent publicly- traded companies. The Document Technology company will continue to be a global leader in document management and document outsourcing with approximately $11 billion in 2015 revenue. The Business Process Outsourcing (BPO) company will be an industry leader that helps clients improve the flow of work by leveraging its expertise in managing transaction-intensive processes and applying innovations to automate and simplify business processes. With approximately $7 billion in 2015 revenue - more than 90% of which is annuity based - the company is focused on attractive growth markets including transportation, healthcare, commercial and government services.
06:46 EDTXRXXerox to separate into two public companies
06:29 EDTFB, MSFTOptions expected to be active: AMZN EA MSFT EWJ FLEX SWKS GOOG GOOGL FB
Subscribe for More Information
06:04 EDTMSFTJefferies keeps Microsoft at Underperform following Q2 results
Subscribe for More Information
05:51 EDTFBFacebook shutting down Parse service
Subscribe for More Information
05:39 EDTPFEPfizer: LIS awards infliximab biosimilar tender to Inflectra, Reuters reports
Pfizer says that the Norwegian Drug Procurement Cooperation has awarded its product Inflectra an infliximab biosimilar tender, Reuters reports. Reference Link
05:11 EDTFBStocks with implied volatility below IV index mean; UA FB
Stocks with implied volatility below IV index mean; Under Armour (UA) 37, Facebook (FB) 32 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use